Your browser doesn't support javascript.
loading
Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer.
Tolaney, Sara M; Im, Young-Hyuck; Calvo, Emiliano; Lu, Yen-Shen; Hamilton, Erika; Forero-Torres, Andres; Bachelot, Thomas; Maur, Michela; Fasolo, Angelica; Tiedt, Ralph; Nardi, Lisa; Stammberger, Uz; Abdelhady, Ahmed M; Ruan, Shiling; Lee, Soo Chin.
Afiliación
  • Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. sara_tolaney@dfci.harvard.edu.
  • Im YH; Department of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Calvo E; Medical Oncology, START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Hospital HM Madrid Norte Sanchinarro, Madrid, Spain.
  • Lu YS; Department of Oncology, National Taiwan University Hospital, Taipei City, Taiwan.
  • Hamilton E; Breast and Gynecologic Cancer Research Program, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee.
  • Forero-Torres A; Clinical Affairs, Seattle Genetics, Seattle, Washington.
  • Bachelot T; Medical Oncology Department, Léon-Bérard Centre, Lyon, France.
  • Maur M; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Fasolo A; Department of Medical Oncology, San Raffaele Hospital - Scientific Institute, Milan, Italy.
  • Tiedt R; Oncology Disease Area, Novartis Pharma AG, Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Nardi L; Translational Clinical Oncology, Novartis, East Hanover, New Jersey.
  • Stammberger U; Translational Clinical Oncology, Novartis Pharma AG, Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Abdelhady AM; Clinical Oncology, Novartis, East Hanover, New Jersey.
  • Ruan S; Early Clinical Biostatistics, Novartis, East Hanover, New Jersey.
  • Lee SC; Department of Haematology-Oncology, National University Hospital, National University Cancer Institute, National University Health System, Singapore.
Clin Cancer Res ; 27(2): 418-428, 2021 01 15.
Article en En | MEDLINE | ID: mdl-32887722
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Fosfatidilinositol 3-Quinasas Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Fosfatidilinositol 3-Quinasas Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Año: 2021 Tipo del documento: Article